Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

VRNA Verona Pharma Plc

54,08

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 10:35:07

Verzögert um 15 Minuten

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Verona Pharma (NASDAQ:VRNA)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Verona Pharma Charts.

Verona Pharma (NASDAQ:VRNA)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Verona Pharma Charts.

News Verona Pharma Plc

Form 8-K - Current report
Dienstag 7 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights
Dienstag 7 Januar 2025 (2 Wochen vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 27 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Montag 25 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Verona Pharma Announces December 2024 Investor Conference Participation
Dienstag 19 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 8 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Verona Pharma to Present at Jefferies London Healthcare Conference
Dienstag 5 November 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 4 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 4 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Montag 4 November 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 2 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Verona Pharma Plc News-Artikel

JP Morgan Chase

Health Care Select Sector

Euro vs Sterling

Deutsche Telekom

Euro vs US Dollar

Energy Select Sector SPDR

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen